Dr. Lal PathLabs Limited Share Price
Equities
LALPATHLAB
INE600L01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,397.90 INR | -0.87% |
|
-3.82% | -5.71% |
| Capitalization | 23TCr 258.54Cr 222.7Cr 207.54Cr 193.08Cr 359.2Cr 385.32Cr 2.38TCr 938.34Cr 11TCr 969.46Cr 949.63Cr 41TCr | P/E ratio 2026 * |
45.3x | P/E ratio 2027 * | 39.1x |
|---|---|---|---|---|---|
| Enterprise value | 22TCr 243.5Cr 209.75Cr 195.47Cr 181.85Cr 338.31Cr 362.92Cr 2.25TCr 883.77Cr 11TCr 913.09Cr 894.41Cr 39TCr | EV / Sales 2026 * |
8x | EV / Sales 2027 * | 7.02x |
| Free-Float |
44.16% | Yield 2026 * |
0.95% | Yield 2027 * | 1.02% |
Last Transcript: Dr. Lal PathLabs Limited
| 1 day | -0.87% | ||
| 1 week | -3.82% | ||
| Current month | -5.71% | ||
| 1 month | -2.21% | ||
| 3 months | -10.46% | ||
| 6 months | -6.00% | ||
| Current year | -5.71% |
| 1 week | 1,364.3 |  | 1,455 |
| 1 month | 1,348 | | 1,520 |
| Current year | 1,364.3 | | 1,514 |
| 1 year | 1,146.78 | | 1,770 |
| 3 years | 881.02 | | 1,826.98 |
| 5 years | 881.02 | | 2,122.75 |
| 10 years | 348.25 | | 2,122.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shankha Banerjee
CEO | Chief Executive Officer | - | 21/05/2024 |
Ved Prakash Goel
DFI | Director of Finance/CFO | - | 10/08/2018 |
| Chief Operating Officer | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Arvind Lal
CHM | Chairman | 76 | 01/04/2020 |
Vandana Lal
BRD | Director/Board Member | 70 | 14/02/1995 |
Rahul Sharma
BRD | Director/Board Member | 65 | 22/07/2005 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.72% | 0.01% | 51 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.87% | -3.82% | +0.88% | +28.71% | 260.81Cr | |
| -2.22% | +0.44% | +39.67% | +488.38% | 3.32TCr | |
| -0.13% | +4.12% | -16.61% | -24.29% | 772Cr | |
| -0.83% | -7.71% | +18.54% | +260.85% | 564.08Cr | |
| +1.56% | -18.13% | +62.36% | +613.51% | 315.87Cr | |
| -12.86% | +39.61% | +137.72% | -4.46% | 254.41Cr | |
| -9.37% | +6.54% | +26.75% | -60.77% | 239.21Cr | |
| -0.61% | -0.61% | - | - | 181.76Cr | |
| -0.74% | -3.65% | -9.30% | +9.31% | 166Cr | |
| +5.89% | +0.90% | +37.80% | +10.36% | 159.68Cr | |
| Average | -2.06% | -3.72% | +33.09% | +146.84% | 623.82Cr | |
| Weighted average by Cap. | -2.03% | -1.59% | +32.26% | +320.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.75TCr 30Cr 26Cr 24Cr 23Cr 42Cr 45Cr 280.78Cr 110.48Cr 1.31TCr 114.15Cr 111.81Cr 4.82TCr | 3.09TCr 34Cr 29Cr 27Cr 26Cr 47Cr 51Cr 315.24Cr 124.05Cr 1.48TCr 128.16Cr 125.54Cr 5.42TCr |
| Net income | 517.43Cr 5.73Cr 4.93Cr 4.6Cr 4.28Cr 7.96Cr 8.54Cr 53Cr 21Cr 247.37Cr 21Cr 21Cr 907.48Cr | 598.69Cr 6.63Cr 5.71Cr 5.32Cr 4.95Cr 9.21Cr 9.88Cr 61Cr 24Cr 286.21Cr 25Cr 24Cr 1.05TCr |
| Net Debt | -1.36TCr -15Cr -13Cr -12Cr -11Cr -21Cr -22Cr -138.67Cr -55Cr -649.41Cr -56Cr -55Cr -2.38TCr | -1.7TCr -19Cr -16Cr -15Cr -14Cr -26Cr -28Cr -173.17Cr -68Cr -810.96Cr -70Cr -69Cr -2.98TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 1,397.90 ₹ | -0.87% | 5,21,271 |
| 14/26/14 | 1,410.20 ₹ | -0.76% | 5,05,949 |
| 13/26/13 | 1,421.00 ₹ | +2.90% | 6,39,672 |
| 12/26/12 | 1,381.00 ₹ | -2.62% | 2,85,518 |
| 09/26/09 | 1,418.20 ₹ | -2.42% | 3,28,317 |
Delayed Quote NSE India S.E., January 16, 2026 at 03:58 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LALPATHLAB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition